Genomed (GEN.WA) Stock Price
Genomed Price
Over the last 9 years Genomed grew revenue by 10.1% annually, reaching 23.01 M PLN. Earnings per share have grown at 86.2% per year over the last 9 years. For Genomed, the net margin of 4.8% is up versus 2.2% a few years ago. At today's price the dividend yield works out to roughly 2.67%. The payout ratio is around 132% of earnings.
Genomed stock price
Genomed business model & stock analysis
Frequently asked questions about Genomed
Converted at the current exchange rate, the Genomed share trades at 8.56 EUR (37.40 PLN).
The revenue cannot currently be calculated for Genomed.
The profit cannot currently be calculated for Genomed.
The P/E ratio cannot be calculated for Genomed at the moment.
The P/S cannot be calculated for Genomed currently.
The Eulerpool Quality Score for Genomed is 2/10.
The ISIN of Genomed is PLGNOMD00024. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genomed is GEN.WA. The ticker symbol is used to trade Genomed shares on the stock exchange.
Genomed stock
Genomed Peer Group
Genomed FIGI
All fundamentals and in-depth analysis of Genomed
Our stock analysis for Genomed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.